China Meheco Group Co (SHSE:600056) Research & Development: ¥159 Mil (TTM As of Mar. 2026)


SHSE:600056 China Meheco Group Co Ltd SHSE:600056
63 GF Score
Price ¥8.58
GF Value ¥10.49
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is China Meheco Group Co Research & Development?

China Meheco Group Co SHSE:600056 -2.39% 63 Research & Development is ¥159 Mil as of Mar. 2026. GuruFocus rates SHSE:600056 with a GF Score™ of 63/100 and a GF Value™ of ¥10.49 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. China Meheco Group Co's Research & Development for the three months ended in Mar. 2026 was ¥35 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥159 Mil.

China Meheco Group Co  (SHSE:600056) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

China Meheco Group Co Research & Development Related Terms

China Meheco Group Co Research & Development Historical Data

* Premium members only.

The historical data trend for China Meheco Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Meheco Group Co Research & Development Chart

China Meheco Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.38 77.33 115.54 125.22 158.38

China Meheco Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.52 32.11 36.50 56.25 34.58
SHSE:600056
63GF Score
China Meheco Group Co Ltd SHSE:600056
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Meheco Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥159 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥159 Mil mean?
China Meheco Group Co (SHSE:600056) has a Research & Development of ¥159 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on China Meheco Group Co and its competitors.
Is China Meheco Group Co's Research & Development too high?
China Meheco Group Co's current Research & Development is ¥159 Mil. Overall, China Meheco Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's Research & Development compare to MCK and COR?
China Meheco Group Co's Research & Development of ¥159 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on China Meheco Group Co and its competitors. China Meheco Group Co's current Research & Development is ¥159 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.49, compared to a current price of ¥8.58 — trading 18.2% below its estimated fair value. The current Research & Development is ¥159 Mil. China Meheco Group Co's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current Research & Development is ¥159 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?

Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued. The current stock price of ¥8.58 is trading 18.2% below its estimated GF Value™ of ¥10.49. GuruFocus considers China Meheco Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600056:

  • Research & Development: ¥159 Mil
  • GF Value™: ¥10.49 vs. price of ¥8.58 (18.2% below fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Meheco Group Co Business Description

Address No. 1 Xiying Street, Floor 18-28, Block B, Building 1, General Times Center, District 1, Fengtai, Beijing, CHN, 100073
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
63GF Score

Get the complete analysis for SHSE:600056

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.58
Price
¥10.49
GF Value